Vici was founded by Dr. Anish Dhanarajan, PhD and Francesca Minale, MEng in 2016 with the goal of becoming a world class pharmaceutical product development company. Vici works hard at identifying unmet pharmaceutical needs that can be solved by drug development through the 505(b)(2) NDA or ANDA pathway. In pursuit of this goal, Vici operates a rapid, low-cost, high quality prototyping R&D facility capable of GMP operations in Maryland, USA.
Vici is an end-to-end pharmaceutical R&D company capable of taking projects from inception through FDA approval.
Our goal is to delight our customers through expertise and innovation in formulation development. We are passionate about solving our customer’s problems. Being R&D specialists, we are focused on our mission to provide innovative solutions, offering you better value in product development.
- Oral Formulation Development
- Parenteral Formulation Development
- Analytical Testing Services
- GMP Clinical Manufacturing
- Regulatory Filing Services
- Technical R&D Consultation
- CMO Selection and Management
2024 © COPYRIGHTS - VICI HEALTH SCIENCES | ALL RIGHTS RESERVED
We need your consent to load the translations
We use a third-party service to translate the website content that may collect data about your activity. Please review the details in the privacy policy and accept the service to view the translations.